Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Introduced

Jan 14, 2026

Last Action

Jan 29, 2026

Session

RI 2026

AI Summary

Get a plain-English explanation of what this bill does, who it affects, and why it matters.

01/29/2026 Committee recommended measure be held for further study

HB 7468

Previous Bill

HB 7350

Next Bill

→

Talk to us

AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES -- THE MATTHEW FEDERICO DIABETIC SAFETY ACT

AI Summary

Status

Primary Sponsors